FINWIRES · TerminalLIVE
FINWIRES

市場動態:摩根大通和摩根士丹利正合作推動利奧製藥在丹麥的潛在IPO

-- 根據彭博社週一援引知情人士報道,摩根大通(JPM)、摩根士丹利(MS)和丹麥銀行正在為利奧製藥(Leo Pharma)在丹麥的潛在首次公開募股(IPO)做準備。 消息人士告訴彭博社,IPO可能在今年進行,利奧製藥可能會聘請更多銀行參與發行。報道稱,由於尚未做出最終決定,計劃仍有可能發生變化。 彭博社稱,利奧製藥2021年的估值約為30億歐元(35.1億美元),其中包括債務。 摩根大通、摩根士丹利、丹麥銀行和利奧製藥均未立即回應的置評請求。 (市場動態新聞來自與全球市場專業人士的對話。這些資訊被認為是來自可靠來源,但可能包含傳聞和猜測。準確性無法保證。)

Price: $307.98, Change: $-1.89, Percent Change: -0.61%

Related Articles

Asia

Sunshine Metals Completes Resource Definition Drilling at Queensland Gold-Dominant Deposit

Sunshine Metals (ASX:SHN) completed resource definition drilling at the Liontown gold panel, a gold-dominant deposit which is part of its Ravenswood consolidated project in Queensland, in late March, according to a Monday Australian bourse filing.The mining study and mineral resource for the Liontown project will be further updated and upgraded in May to incorporate results from the grade control drilling program.

$ASX:SHN
Asia

Wanxiang Qianchao Q1 Profit Down 16%; Shares Slide 3%

Wanxiang Qianchao (SHE:000559) posted first-quarter attributable net profit of 246.8 million yuan, down 16% from 293.3 million yuan the previous year.Earnings per share declined to 0.074 yuan from 0.089 yuan, according to a weekend filing with the Shenzhen bourse.Operating revenue slipped 20% year over year to 2.80 billion yuan from 3.50 billion yuan.Shares of the auto parts manufacturer declined 3% in recent trade.

$SHE:000559
Asia

Eng Kah Seeks 10% Share Buyback Mandate; Shares Rise 3%

Eng Kah (KLSE:ENGKAH) is seeking its shareholders' approval to renew share buyback authority to purchase up to 10% of the issued shares in the company's upcoming annual general meeting, according to a Friday Malaysian bourse filing.Shares gained about 3% in Monday's afternoon trade.The manufacturer of cosmetics, personal care, household, and perfume products will share a detailed statement of the repurchase plan with shareholders in due time.

$KLSE:ENGKAH